Public Contracts Scotland · Contract
NP47725a Emicizumab (Indication Specific)
A public procurement published by NHS Education for Scotland via Public Contracts Scotland.
- —
- Award value
- —
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Contract
- Stage
Overview
Supply of Emicizumab (Indication Specific) to NHS Scotland.
Key details
- Source
- Public Contracts Scotland
- Lifecycle stage
- Contract
- Status
- complete
- CPV classification
- 33600000
- Currency
- GBP
- Total award value
- —
- Tender value
- —
- First published
- 27 Oct 2025
- Last updated
- 27 Oct 2025
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Tayside Council on Alcohol | SC097522 | — | — | — |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from NHS Education for Scotland
FAQs about this procurement
Who is the buyer for "NP47725a Emicizumab (Indication Specific)"?
NP47725a Emicizumab (Indication Specific) is a UK public-sector procurement published by NHS Education for Scotland via Public Contracts Scotland.
Has "NP47725a Emicizumab (Indication Specific)" been awarded?
Yes — 1 award is recorded. The current lifecycle stage is "Contract".
Which suppliers are involved in "NP47725a Emicizumab (Indication Specific)"?
1 supplier is linked: Tayside Council on Alcohol.
When was "NP47725a Emicizumab (Indication Specific)" published?
It was first published on 27 Oct 2025 and last updated on 27 Oct 2025, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable